Patient Risk Stratification Market by Type (Predictive Risk Stratification, Concurrent Risk Stratification, Retrospective Risk Stratification & Others), By Mode of Delivery Model (Cloud-based, On-premises & Others), by Component (Software & Services), by Application ( Risk Adjustment, Clinical Workflow, Revenue Cycle Management & Others), by End-User (Healthcare Providers, Healthcare Payers & Others), and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits - Forecast 2023-2030

Industry : Healthcare | Pages : 190 Pages | Published On : Jun 2024

The Patient Risk Stratification Market is Valued USD 1.54 Billion in 2023 and projected to reach USD 10.06 Billion by 2030, growing at a CAGR of 20.58% During the Forecast period of 2023-2030.

Market Overview

Patient risk stratification is the process of identifying and grouping patients according to their risk of developing certain outcomes such as hospital readmission or complications from chronic diseases. It allows providers to target interventions toward patients who will benefit the most by patient risk satisfaction software and services. The key advantages of patient risk stratification include improved patient outcomes, reduced healthcare costs, and better population health management. The market's expansion can be ascribed to the rising demand for patient stratification with applications in software, services and other. At the international level, the research offers insights into the profitable prospects in the patient risk stratification market. For the anticipated time, the study also provides a precise cost, segmentation, trends, region, and commercial development. The software segment accounts for the largest share owing to the growing adoption of predictive analytics and data integration solutions for risk stratification. The patient risk stratification market is experiencing significant growth driven by several key factors. Technological advancements, particularly in data analytics, artificial intelligence, and machine learning, have revolutionized risk assessment accuracy and efficiency. This is particularly crucial given the rising burden of chronic diseases globally, prompting healthcare providers to prioritize early identification and intervention for high-risk patients.

Patient Risk Stratification Market Size

Market Size ValueUSD 1.54 Billion in 2023
Market Size ValueUSD 10.06 Billion by 2030
Forecast Period2023-2030
Base Year 2023
Historic Data2020

Top key players are: lightbeam health solutions, nvision health, rldatix, llc, cerner corporation, ibm corporation, optum, inc., Allscripts Healthcare Solutions, Inc., Epic System Corporation, Wellcentive, ZeOmega, Avero Diagnosis, Lexis Nexis Risk Solutions, Verisk Analytics, Inc, Health Catalyst, Inc., Milliman, Inc., CitiusTech Inc.,  And others. Market players are focusing on product advancements, such as user-friendly designs and advanced fire suppression technologies, to cater to the evolving needs of consumers worldwide.

Increasing incidence of chronic diseases:

A significant global health challenge is presented by the surge in chronic diseases which include cardiovascular diseases, diabetes, cancer, respiratory diseases, and mental health disorders. The upsurge in this ailment has put a lot of pressure on the healthcare systems across the world. The rise of elderly populations passive lifestyles unhealthy nutrition environmental issues and genetic factors are part of the factors that have led to this trend." It is important for healthcare providers as well as policy masters to provide treatment for who may be suffering from these illnesses since they need continuous medical attention if they pass away early hence cannot generate money which may result into poverty consequently affecting the American economy leading to untold suffering that has afflicted many. Public health campaigns, detection at early-stage initiatives, tailor made medicine, improvement in telemedicine and other areas are crucial in lessening and managing the impacts of persistent illnesses. Therefore, for countries to have reduced rates of chronic diseases, medical researchers, health care professionals, policy makers and other professionals must work together as partners.

Market Dynamics


  • Increasing incidence of chronic diseases
  • The necessity to lower healthcare costs
  • Supportive government initiatives
  • Developments in analytics, Artificial Intelligence (AI), and machine learning have progressed significantly


  • Technological advancement in healthcare.
  • Utilizing real-world data (RWD) and large datasets
  • Integration of social factors impacting health

Utilizing real-world data (RWD) and large datasets:

There has been a growing importance of utilization of real-world data (RWD) and big datasets in the healthcare industry. RWD comprises information that is not obtained during traditional clinical trials like electronic health records (EHRs), insurance claims as well as patient registries etcetera. This massive interconnectivity among all these datasets allows stakeholders such as health care providers, researchers and even policy makers to achieve better understanding regarding individual patients’ results after treatments as well as effectiveness of therapeutical interventions. Healthcare experts through examination of large sample sizes can detect tendencies and relationships that are otherwise hard to notice in controlled clinical settings. This is likely to result in treatment plans which are better targeted and can be tailored to individual circumstances as well as earlier identification of possible side effects or complications. Additionally, the comprehension of population health could be improved with the help of RWD making it easier to develop specific public health interventions or policies.

North America Dominates the market for Patient Risk Stratification:

North America leads the market for patient risk stratification, driven by several key factors, including advanced healthcare infrastructure, substantial investments in healthcare technology, and a high adoption rate of innovative medical solutions. The United States, in particular, stands out due to its extensive network of healthcare providers, research institutions, and tech companies specializing in health analytics. The region's dominance is further reinforced by the presence of major market players and ongoing advancements in artificial intelligence and machine learning. Additionally, favourable government policies and funding initiatives focused on improving healthcare outcomes and reducing costs through preventive care and personalized medicine play a significant role in maintaining North America's leading position in this market.

Predictive risk stratification segment holds the largest market share in patient risk stratification market:

The Predictive Risk Stratification segment holds the largest market share in the Patient Risk Stratification market. This segment's prominence is largely due to its use of data analytics and predictive modelling techniques to identify individuals at high risk for developing health conditions or experiencing adverse health events. By harnessing extensive data from various sources, including electronic health records, insurance claims, and wearable devices, predictive risk stratification provides valuable insights that enable proactive interventions and personalized care plans. The increasing adoption of artificial intelligence and machine learning technologies has significantly improved the accuracy and efficiency of predictive risk models, further propelling the segment's growth. Healthcare providers are increasingly recognizing the benefits of predictive risk stratification in enhancing patient outcomes, reducing healthcare costs, and optimizing resource allocation.

Segmentations analysis of patient risk stratification market: -

Major market segments:

  • By Type:
  • Predictive Risk Stratification
  • Concurrent Risk Stratification
  • Retrospective Risk Stratification
  • Others
  • By Mode of Delivery Model:
  • Cloud-based
  • On-premises
  • Others
  • By Component:
  • Software
  • Services
  • By Application:
  • Risk Adjustment
  • Clinical Workflow
  • Revenue Cycle Management
  • Others
  • By End User:
  • Healthcare Providers
  • Healthcare Payers
  • Others
  • By Region:
    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
      • Chile
      • Peru
      • Rest of Latin America
    • Europe
      • Germany
      • France
      • Italy
      • Spain
      • U.K.
      • BENELUX
      • CIS & Russia
      • Nordics
      • Austria
      • Poland
      • Rest of Europe
    • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Thailand
    • Indonesia
    • Malaysia
    • Vietnam
    • Australia & New Zealand
    • Rest of Asia Pacific
    • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Nigeria
    • Egypt
    • Israel
    • Turkey
    • Rest of MEA

Recent Developments:

  • In February 2023, Avero Diagnostics, a company specializing in cancer diagnostics, introduced the AMBLor Test to enabling risk stratification for early-stage melanoma.
  • In January 2022, PreciseDx, a company specializing in cancer risk stratification, revealed that it had secured a Series A preferred investment of US$ 10.7 million in 2021. This funding was earmarked to bolster the continual development and commercialization of its AI-driven risk classification platform.

Answers to Following Key Questions:

  • What will be the patient risk stratification market’s trends & growth rate? What analysis has been done of the prices, sales, and volume of the top producers in the patient risk stratification market?
  • What are the main forces behind worldwide patient risk stratification market? Which companies dominate patient risk stratification market?
  • Which companies dominate patient risk stratification market? Which business possibilities, dangers, and tactics did they embrace in the market?
  • What are the global insight engines industry's suppliers' opportunities and dangers in patient risk stratification market?
  • What is the insight engines industry's regional sales, income, and pricing analysis? In the patient risk stratification market, who are the distributors, traders, and resellers?
  • What are the main geographic areas for various trades that are anticipated to have astounding expansion over the patient risk stratification market?
  • What are the main geographical areas for various industries that are anticipated to observe astounding expansion for patient risk stratification market?
  • What are the dominant revenue-generating regions for patient risk stratification market, as well as regional growth trends?
  • By the end of the forecast period, what will the market size and growth rate be?
  • What are the main patient risk stratification market trends that are influencing the market's expansion?
  • Which key product categories dominate patient risk stratification market? What is patient risk stratification market’s main applications?
  • In the coming years, which patient risk stratification market technology will dominate the market?



Table and Figures


At MarketDigits, we take immense pride in our 360° Research Methodology, which serves as the cornerstone of our research process. It represents a rigorous and comprehensive approach that goes beyond traditional methods to provide a holistic understanding of industry dynamics.

This methodology is built upon the integration of all seven research methodologies developed by MarketDigits, a renowned global research and consulting firm. By leveraging the collective strength of these methodologies, we are able to deliver a 360° view of the challenges, trends, and issues impacting your industry.

The first step of our 360° Research Methodology™ involves conducting extensive primary research, which involves gathering first-hand information through interviews, surveys, and interactions with industry experts, key stakeholders, and market participants. This approach enables us to gather valuable insights and perspectives directly from the source.

Secondary research is another crucial component of our methodology. It involves a deep dive into various data sources, including industry reports, market databases, scholarly articles, and regulatory documents. This helps us gather a wide range of information, validate findings, and provide a comprehensive understanding of the industry landscape.

Furthermore, our methodology incorporates technology-based research techniques, such as data mining, text analytics, and predictive modelling, to uncover hidden patterns, correlations, and trends within the data. This data-driven approach enhances the accuracy and reliability of our analysis, enabling us to make informed and actionable recommendations.

In addition, our analysts bring their industry expertise and domain knowledge to bear on the research process. Their deep understanding of market dynamics, emerging trends, and future prospects allows for insightful interpretation of the data and identification of strategic opportunities.

To ensure the highest level of quality and reliability, our research process undergoes rigorous validation and verification. This includes cross-referencing and triangulation of data from multiple sources, as well as peer reviews and expert consultations.

The result of our 360° Research Methodology is a comprehensive and robust research report that empowers you to make well-informed business decisions. It provides a panoramic view of the industry landscape, helping you navigate challenges, seize opportunities, and stay ahead of the competition.

In summary, our 360° Research Methodology is designed to provide you with a deep understanding of your industry by integrating various research techniques, industry expertise, and data-driven analysis. It ensures that every business decision you make is based on a well-triangulated and comprehensive research experience.

Customize your Report
• Tailored advice to Drive your Performance
• Product Planning Strategy
• New Product Stratergy
• Expanded Research Scope
• Comprehensive Research
• Strategic Consulting
• Provocative and pragmatic
• Accelerate Revenue & Growth
• Evaluate the competitive landscape
• Optimize your partner network
• Analyzing industries
• Mapping trends
• Strategizing growth
• Implementing plans
A comprehensive cogent custom study with Analyzing Industries, Mapping Trends, Straterging growth & Implementing Plans. An in-depth and breadth of composite research, which gives complete support of the generation and evaluation of growth opportunities, and best practices recognition to help increase the revenue. Request a Custom Research below.
Request Customization

Covered Key Topics

Growth Opportunities

Market Growth Drivers

Leading Market Players

Company Market Share

Market Size and Growth Rate

Market Trend and Technological

Research Assistance

We will be happy to help you find what you need. Please call us or write to us:

+1 510-730-3200 (USA Number)